மருந்து ப்ரைஸ் ஒழுங்குமுறை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து ப்ரைஸ் ஒழுங்குமுறை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து ப்ரைஸ் ஒழுங்குமுறை Today - Breaking & Trending Today

Pharma industry pushes back on drug price control board


March 10, 2021 | 7:28 pm
Font Size
AAA
DRUGMAKERS said further price controls on their products will hinder the industry in recovering from the economic downturn triggered by the pandemic.
Responding Wednesday to a legislative proposal to establish a price board for drugs, Pharmaceutical and Healthcare Association of the Philippines (PHAP) Trustee Jannette Alcantara Jakosalem said price controls will be an added burden to the industry on top of the difficult economic environment.
“Like many industries, the pharmaceutical industry has not recovered from the pandemic. The contraction of the market reached up to minus 18% in 2020. This is evidence of our struggles. On top of our struggles, the government imposed mandatory price reductions of up to 50% for 133 pharmaceutical products,” she said at a hearing of the House Committee on Trade and Industry. ....

Jannette Alcantara Jakosalem , Gillianm Cortez , Rodrigor Duterte , Vic Dimagiba , Laban Konsyumer Inc , European Union , Healthcare Association Of The Philippines , House Committee On , Healthcare Association , Trustee Jannette Alcantara Jakosalem , House Committee , House Bills , Drug Price Regulatory , Republic Act , Universally Accessible Cheaper , Quality Medicines Act , President Vic Dimagiba , Executive Order , President Rodrigo , ஐரோப்பிய தொழிற்சங்கம் , சுகாதாரம் சங்கம் ஆஃப் தி பிலிப்பைன்ஸ் , வீடு குழு ஆன் , சுகாதாரம் சங்கம் , வீடு குழு , வீடு பில்கள் , மருந்து ப்ரைஸ் ஒழுங்குமுறை ,

German Government Answers Questions on Medical Cannabis


Prohibition Partners’ comment:
This is the first time that re-exported quantities of medical cannabis from the country have been published. See the discussion on the growth of imports to the German market here.
Question 3
Answer
Prohibition Partners’ comment: We estimate over 128,000 patients receive medical cannabis in Germany annually.
Question 4
Answer (data translated by Prohibition Partners)
Note, several other conditions were cited at 1% frequency or less. Also note in 33% of cases, the course of medication was discontinued before one year.
Question 5
Can you explain why 40% of applications for reimbursement of medical cannabis are rejected by insurers, considering rejection is only meant for ‘exceptional’ cases? ....

City Of , United Kingdom , Conor Obrien , London Stock Exchange , Conoro Brien , Die Linke , Prohibition Partners , Federal Government , Drug Price Regulation , European Cannabis , London Stock , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , கோனார் ஓபிறீேன் , லண்டன் ஸ்டாக் பரிமாற்றம் , இறக்க லிங்கே , ப்ரோஹிபிஶந் கூட்டாளர்கள் , கூட்டாட்சியின் அரசு , மருந்து ப்ரைஸ் ஒழுங்குமுறை , ஐரோப்பிய கஞ்சா , லண்டன் ஸ்டாக் ,